RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Iterum Therapeutics - Stock

Iterum Therapeutics Dividend 2024

Iterum Therapeutics Dividend

0 USD

Iterum Therapeutics Dividend yield

Ticker

ITRM

ISIN

IE00BF3W0Q35

WKN

A2JMZP

How much dividend does Iterum Therapeutics 2024 pay?

According to the latest status from June 2024, Iterum Therapeutics paid a total of 0 USD per share in dividends within the last 12 months. With the current Iterum Therapeutics price of 1.48 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Iterum Therapeutics Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Iterum Therapeutics Dividend Safe?

Iterum Therapeutics has been increasing the dividend for 0 years.

Over the past 8 years, Iterum Therapeutics has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Iterum Therapeutics's Dividend Distributions

Iterum Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Iterum Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Iterum Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Iterum Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Iterum Therapeutics Aktienanalyse

What does Iterum Therapeutics do?

Iterum Therapeutics is an Irish biotechnology company that focuses on developing antibiotics for serious bacterial infections. The company was founded in 2015 and has since undergone several successful financing rounds. The business model of Iterum Therapeutics is based on the discovery, development, and commercialization of novel anti-infectives that specialize in hard-to-reach or resistant bacteria. The company has developed a strong pipeline of antibiotic products that aim to combat the growing threat of antibiotic resistance. Iterum Therapeutics operates in several sectors, including clinical development, manufacturing, and marketing of antibiotic products. The company collaborates with leading industry players to ensure the effectiveness and safety of its products. One of Iterum Therapeutics' products is Sulopenem, a novel antibiotic specifically developed for treating infections caused by various types of bacteria. Sulopenem has shown promise in clinical studies and has the potential to play a significant role in combating antibiotic resistance. In addition, Iterum Therapeutics is also developing other antibiotic products focusing on combating bacteria responsible for severe infections, including Pseudomonas aeruginosa and Enterobacteriaceae. Iterum Therapeutics has a strong research and development department that focuses on the discovery and development of new antibiotic products. The company works closely with leading universities and research institutions to build a strong pipeline of innovative anti-infectives. The products of Iterum Therapeutics have the potential to make a significant contribution to combating antibiotic resistance and serious infections. The company is committed to further advancing the growth of its pipeline and maximizing the potential of its products to improve the health of patients worldwide. Iterum Therapeutics is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Iterum Therapeutics Stock

How much dividend does Iterum Therapeutics pay?

Over the past 12 months, Iterum Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Iterum Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Iterum Therapeutics?

The current dividend yield of Iterum Therapeutics is .

When does Iterum Therapeutics pay dividends?

Iterum Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Iterum Therapeutics?

Iterum Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Iterum Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Iterum Therapeutics located?

Iterum Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Iterum Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Iterum Therapeutics from 6/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Iterum Therapeutics pay the last dividend?

The last dividend was paid out on 6/6/2024.

What was the dividend of Iterum Therapeutics in the year 2023?

In the year 2023, Iterum Therapeutics distributed 0 USD as dividends.

In which currency does Iterum Therapeutics pay out the dividend?

The dividends of Iterum Therapeutics are distributed in USD.

Andere Kennzahlen von Iterum Therapeutics

Our stock analysis for Iterum Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Iterum Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.